Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

23,866 signal articles · 376 in last 24h · 113,458 total before filter · latest 33m ago
376last 24h
2046last 7d
336● bullish (7d)
180● bearish (7d)
204publishers
AllMacro331Earnings1094M&A95Regulatory24Product18Analyst22
✕ clear all filtersticker: AVGOSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
This Stock is My Biggest Bet For 2026
24/7 Wall St.31d agoneutral
This Stock is My Biggest Bet For 2026

One stock keeps earning a larger slice of my portfolio every quarter, and it is not because the thesis is obvious. Here is the specific combination of forces that keeps pulling my money back.

Why the KOSPI is pulling back and what it means
Yahoo Finance Video31d agoneutralVIDEO
Why the KOSPI is pulling back and what it means

Yahoo Finance Executive Editor Brian Sozzi sits down with Yahoo Finance Markets and Data Editor Jared Blikre to break down the recent KOSPI pullback, what's driving the decline, and what it could mean for global markets and investors.

Forget Hyperscalers: Here Are the AI Gold Rush Winners to Buy Now
24/7 Wall St.31d agobullish
Forget Hyperscalers: Here Are the AI Gold Rush Winners to Buy Now

While the biggest names in tech burn through a historic spending spree, a small cluster of suppliers is quietly printing cash at a pace that has no precedent in this industry. Understanding who wins at each stage of the AI cycle could completely change how you position your portfolio.

What Investors Keep Asking About NVDA
Trefis31d agoneutral
What Investors Keep Asking About NVDA

After a historic run, the critical questions for NVIDIA are no longer about this quarter's numbers but where the next layers of growth will come from and if the company can actually execute on its breathtakingly complex roadmap.

AI Chips Today - AI Advancements Revolutionize Drug Discovery and Cancer Treatment
Simply Wall St.31d agoneutral
AI Chips Today - AI Advancements Revolutionize Drug Discovery and Cancer Treatment

Recent developments in the AI chip sector include a notable collaboration between VERAXA Biotech and Ardigen. This partnership focuses on integrating artificial intelligence into drug discovery processes to enhance VERAXA's BiTAC pipeline, targeting cancer treatments. The AI will aid in selecting synergistic cancer target pairs, potentially improving therapeutic outcomes by reducing toxicity and systemic effects. This initiative highlights the growing role of AI chips in revolutionizing...